Bringing solutions to genetic testing.
GoPath's GeneticsNow® Series includes a collection of next-generation sequencing panels that detect germline variants associated with an increased risk for various hereditary cancers. Our germline tests are clinical grade, with fast turnaround times and actionable results. We also have in-house contracted genetic counselors to aid in the interpretation of results and to provide guidance to patients.
This COMPREHENSIVE GERMLINE PANEL analyzes 88 clinically-relevant genes that are associated with genetic disorders, including most hereditary cancers.
PROSTATENOW is a germline test for people with prostate cancer. This test can be used to predict prognosis among men with localized prostate cancer, predict therapeutic responses for advanced patients, and predict cancer risk among unaffected men.
BRCANOW is a next-generation sequencing panel for people with a personal or family history of breast or ovarian cancer.
LYNCHNOW is a cost-effective, screening tool that rapidly detects mutations that cause Lynch syndrome.
DIABETESNOW is a unique genetic panel that tests for 16 genes associated with MODY, syndromic, neonatal, and mitochondrial causes of monogenic diabetes. It also includes pan-ancestry type 1 and 2 diabetes polygenic risk scores (PRS) and the probability of type 1 diabetes (GenProb-T1D).
Test menu options for those products
Breast and Ovarian cancers
BRCA1/2 del/dup analysis
BRCA1/2 del/dup analysis
Breast and Ovarian cancers
30-gene panel
30-gene panel
Most Types of Cancer
88-gene panel
88-gene panel
For Diabetes Type 1 and Type 2
16-gene panel + Polygenic Risk Score
16-gene panel + Polygenic Risk Score
Colorectal Cancer
5-gene panel
5-gene panel
Colorectal Cancer
32-gene panel
32-gene panel
Prostate Cancer
23-gene panel + Genetic Risk Score
23-gene panel + Genetic Risk Score
